• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国的糖尿病 第一部分:流行病学与风险因素

Diabetes in China part 1: epidemiology and risk factors.

作者信息

Xu Yu, Lu Jieli, Li Mian, Wang Tiange, Wang Kan, Cao Qiuyu, Ding Yi, Xiang Yu, Wang Siyu, Yang Qianqian, Zhao Xuan, Zhang Xiaoyun, Xu Min, Wang Weiqing, Bi Yufang, Ning Guang

机构信息

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, National Research Center for Translational Medicine, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, National Research Center for Translational Medicine, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Lancet Public Health. 2024 Dec;9(12):e1089-e1097. doi: 10.1016/S2468-2667(24)00250-0. Epub 2024 Nov 20.

DOI:10.1016/S2468-2667(24)00250-0
PMID:39579774
Abstract

The prevalence of diabetes in China is rapidly increasing. China now has the largest number of people living with diabetes worldwide, accounting for approximately one-quarter of the global diabetes population. Since the late 1970s, China has experienced profound changes and rapid economic growth, leading to shifts in lifestyle. Changing dietary patterns, reduced physical activity, and stress have contributed to the growing prevalence of overweight and obesity, which are important determinants potentiating the link between insulin resistance and diabetes. Social and environmental factors, such as education, air pollution, and exposure to endocrine-disrupting chemicals, have also contributed to the growing diabetes epidemic in China. The country has one of the fastest ageing populations in the world, which forecasts continued increases in the prevalence of diabetes and its complications. This Review provides an overview of the ongoing diabetes epidemic and risk factors, providing evidence to support effective implementation of public health interventions to slow and prevent the diabetes epidemic in China.

摘要

中国糖尿病的患病率正在迅速上升。目前,中国是全球糖尿病患者人数最多的国家,约占全球糖尿病患者总数的四分之一。自20世纪70年代末以来,中国经历了深刻的变革和快速的经济增长,导致生活方式发生了转变。饮食模式的改变、体力活动的减少以及压力,都促使超重和肥胖的患病率不断上升,而超重和肥胖是加剧胰岛素抵抗与糖尿病之间联系的重要决定因素。社会和环境因素,如教育、空气污染以及接触内分泌干扰化学物质,也推动了中国糖尿病流行情况的加剧。中国是世界上人口老龄化速度最快的国家之一,预计糖尿病及其并发症的患病率将持续上升。本综述概述了当前的糖尿病流行情况及危险因素,为支持在中国有效实施公共卫生干预措施以减缓并预防糖尿病流行提供依据。

相似文献

1
Diabetes in China part 1: epidemiology and risk factors.中国的糖尿病 第一部分:流行病学与风险因素
Lancet Public Health. 2024 Dec;9(12):e1089-e1097. doi: 10.1016/S2468-2667(24)00250-0. Epub 2024 Nov 20.
2
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
3
Diabetes in China: epidemiology, pathophysiology and multi-omics.中国的糖尿病:流行病学、病理生理学与多组学
Nat Metab. 2025 Jan;7(1):16-34. doi: 10.1038/s42255-024-01190-w. Epub 2025 Jan 14.
4
Obesity and diabetes epidemics: cancer repercussions.肥胖与糖尿病流行:对癌症的影响
Adv Exp Med Biol. 2008;630:72-93. doi: 10.1007/978-0-387-78818-0_6.
5
Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China.中国正面临肥胖流行及其后果吗?中国肥胖与慢性病的趋势。
Int J Obes (Lond). 2007 Jan;31(1):177-88. doi: 10.1038/sj.ijo.0803354. Epub 2006 May 2.
6
Shifts in population dietary patterns and physical inactivity as determinants of global trends in the prevalence of diabetes: an ecological analysis.人口饮食模式的转变和身体活动不足作为全球糖尿病患病率趋势的决定因素:一项生态学分析。
Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1105-11. doi: 10.1016/j.numecd.2014.05.005. Epub 2014 May 24.
7
Association of the Haze and Diabetes in China.中国雾霾与糖尿病的相关性研究。
Curr Diabetes Rev. 2021;17(1):11-20. doi: 10.2174/1573399816666200109095511.
8
Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study.中国成年人中可改变的风险因素对糖尿病发病风险的影响存在年龄差异:一项全国性、基于人群的队列研究。
Lancet Healthy Longev. 2021 Oct;2(10):e618-e628. doi: 10.1016/S2666-7568(21)00177-X. Epub 2021 Sep 7.
9
Projected and observed diabetes epidemics in China and beyond.中国及其他国家的预估和现患糖尿病流行情况。
Curr Cardiol Rep. 2012 Feb;14(1):106-11. doi: 10.1007/s11886-011-0227-9.
10
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.基于网络的项目对学龄儿童肥胖症减轻的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248.

引用本文的文献

1
Temporal changes in the burden of type 2 diabetes mellitus across the BRICS, 1990-2021: a comprehensive analysis for the global burden of disease study 2021.1990 - 2021年金砖国家2型糖尿病负担的时间变化:2021年全球疾病负担研究的综合分析
BMC Public Health. 2025 Aug 30;25(1):2982. doi: 10.1186/s12889-025-23786-x.
2
DJ-1 Serves as a Central Regulator of Diabetes Complications.DJ-1作为糖尿病并发症的核心调节因子。
Curr Issues Mol Biol. 2025 Aug 4;47(8):613. doi: 10.3390/cimb47080613.
3
Global, Regional, and National Burden of Blindness due to Diabetic Retinopathy, 1990-2021.
1990 - 2021年糖尿病性视网膜病变导致的全球、区域和国家失明负担
Ophthalmol Ther. 2025 Aug 27. doi: 10.1007/s40123-025-01230-y.
4
Application of chemotherapy combined with immunotherapy in first-line treatment of advanced esophageal cancer: fluorouracil or paclitaxel? - a meta-analysis.化疗联合免疫疗法在晚期食管癌一线治疗中的应用:氟尿嘧啶还是紫杉醇?——一项荟萃分析
Front Oncol. 2025 Aug 11;15:1607715. doi: 10.3389/fonc.2025.1607715. eCollection 2025.
5
Sulforaphane attenuates aldose reductase-mediated platelet dysfunction in high glucose-stimulated human platelets via downregulation of the Src/ROS/p53 signaling pathway.萝卜硫素通过下调Src/ROS/p53信号通路减轻高糖刺激的人血小板中醛糖还原酶介导的血小板功能障碍。
Front Nutr. 2025 Aug 1;12:1663245. doi: 10.3389/fnut.2025.1663245. eCollection 2025.
6
Shared diagnostic genes and potential mechanisms between intervertebral disc degeneration and diabetes mellitus revealed by integrated transcriptomic analysis and machine learning.综合转录组分析和机器学习揭示椎间盘退变与糖尿病之间的共享诊断基因和潜在机制
Front Endocrinol (Lausanne). 2025 Jul 18;16:1576826. doi: 10.3389/fendo.2025.1576826. eCollection 2025.
7
Facile fabrication of antioxidative and antibacterial hydrogel films to accelerate infected diabetic wound healing.简便制备抗氧化和抗菌水凝胶薄膜以加速感染性糖尿病伤口愈合。
Bioact Mater. 2025 Jul 21;53:386-403. doi: 10.1016/j.bioactmat.2025.07.026. eCollection 2025 Nov.
8
Uric Acid Causes Pancreatic β Cell Death and Dysfunction via Modulating CHOP-Mediated Endoplasmic Reticulum Stress Pathways.尿酸通过调节CHOP介导的内质网应激途径导致胰腺β细胞死亡和功能障碍。
Diseases. 2025 Jul 7;13(7):213. doi: 10.3390/diseases13070213.
9
The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy.YAP/TAZ在糖尿病心肌病发展中的机械作用
Curr Issues Mol Biol. 2025 Apr 23;47(5):297. doi: 10.3390/cimb47050297.
10
Comparison of cardiovascular risk assessment protocols and achievement of risk factor targets in patients with type 2 diabetes.2型糖尿病患者心血管风险评估方案及危险因素目标达成情况的比较
Front Endocrinol (Lausanne). 2025 Jul 3;16:1572202. doi: 10.3389/fendo.2025.1572202. eCollection 2025.